
Actor Dipika Kakar undergoes mammography: Do women cancer survivors need to continue their mammograms?
In a vlog, Kakar says that she consulted the doctor after she developed pain on her left side. Her first mammogram showed enlarged lymph nodes, which can arise from various reasons, including infection. Her doctor had said then that it didn't look suspicious but it would be good to do a repeat scan after three months. Other doctors said the pain could be the result of a muscle injury. She mentioned how, because of her surgery and her recovery, her time to get the mammography done had exceeded three months. Now the mammography has shown that her lymph nodes had shrunk.
'Women cancer survivors need to watch out for spread or recurrence once they are on follow-up therapy protocol. And that's why a mammogram is advised. Generally, we do not advise mammography alongside PET scan (which assesses spread, metastasis and treatment response) because any anomaly would automatically be picked up by the latter. We do not suggest it for all liver cancer survivors either without assessing individual cases and risks. But in cases of breast cancer, some survivors may be suggested to undergo mammography surveillance even while undergoing PET scans,' says Dr Jeyhan Dhabhar, consultant, medical oncology, Jaslok Hospital, Mumbai.
No matter where you develop cancer, you need surveillance through imaging tests of the breast. Unless the woman is a breast cancer survivor, we suggest mammograms to women survivors of other cancers only after they have completed their treatment protocol. Once they are on routine follow-up, we suggest mammography once in 12 to 18 months, the same as we advise any woman over the age of 45.
However if the women are BRCA-positive, then there is a different screening protocol even if they develop cancer in any other part of the body.
BRCA-positive women have a higher lifetime risk of developing breast and ovarian cancers due to inherited mutations in the BRCA1 or BRCA2 genes. Women with BRCA1 mutations have a 72% lifetime risk of breast cancer, while those with BRCA2 mutations have a 69% risk. Ovarian cancer risk also increases.
So if a BRCA-positive woman has recovered from cancer in another part of the body, we recommend breast sonography once in six months and an MRI breast once in six months for monitoring purposes. Breast ultrasound uses sound waves to create images and are often used to further investigate abnormalities found during mammograms.
Once they are through with the treatment protocol, they should because mammograms can tell you about breast tissue anomalies or new growth. While breast cancer can sometimes spread to the liver, liver cancer does not directly increase the risk of breast cancer.
You need to screen for new growth. Especially if you've only had one breast removed, you should be screening the other breast to rule out abnormal tissue growth.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hindustan Times
10 hours ago
- Hindustan Times
Gujarat HC orders CRPF to promote HIV-positive officer in ministerial posts
The Gujarat high court has ordered the Central Reserve Police Force (CRPF) to promote a woman officer to the Inspector rank, ruling that the force could not stop her promotion to the ministerial post merely on the ground that she was HIV-positive. The Gujarat high court ordered CRPF to promote her as Inspector (Ministerial) with effect from the date her juniors were promoted, and consider her for promotion to the post of Assistant Commandant (Ministerial) The high court ordered CRPF to promote her as Inspector (Ministerial) with effect from the date her juniors were promoted, and consider her for promotion to the post of Assistant Commandant (Ministerial) by placing her in the gradation list along with her juniors. A special departmental promotion committee should be conducted to consider the petitioner's candidature. 'Upon consideration, if the petitioner is found fit on all other aspects, she shall be given promotion to the post of Assistant Commandant (Ministerial) from the date the junior(s) to her have been promoted against the vacancies of the year 2024-25,' a bench of chief justice Sunita Agarwal and justice Pranav Trivedi said in its verdict on Monday. The detailed judgment was uploaded to the high court's website on Tuesday. The court ruled that the entire exercise should be completed within two months. The petitioner, a CRPF officer who was diagnosed HIV-positive in 2013, was denied promotion on multiple occasions despite being medically classified as Shape-I — the highest fitness level — between 2017 and 2022. In 2024, she was temporarily placed in Shape-II for 12 weeks, despite a CD4 count of 562. On that basis, her name was excluded from the list of officers considered for promotion to the post of Assistant Commandant (Ministerial). 'Applying the medical category Shape I as an essential (pre-requisite) condition for promotion of the force personnel in all groups/ranks/cadres in the CPMF and, thus, denying promotion to HIV/AIDS +ve persons who are 'protected persons' within the HIV/AIDS (Prevention & Control) Act' 2017 resulted in arbitrary exercise of powers at the ends of the respondents,' the court said. The CRPF had tried to argue that medical classification in Shape-I was a mandatory requirement for promotion and cited Standing Orders and Recruitment Rules. It also sought to reason that promotion could not be claimed as a matter of right and that the petitioner's exclusion was based on applicable policy and medical reports. It also claimed that while she had been temporarily upgraded to Shape-I in the past, she did not appear for timely review medical examinations as required, including in 2024, which affected her eligibility. The officer, on the other hand, said that she had been consistently declared fit for service, with CD4 counts well above the clinical minimum of 200 cells/microlitre, and that she had been arbitrarily downgraded in the medical system without consistency. She said she was denied promotion despite meeting the eligibility and superior Annual Performance Appraisal Reports. She also argued that applying the same physical medical standards to ministerial staff — who do not serve in combat or field duties — was irrational and discriminatory. The bench agreed with the petitioner's arguments. The court ruled that the current rules and standing orders placed an unlawful restriction on DPCs by denying them discretion to assess overall fitness. It stated: 'It seems that HIV/AIDS +ve persons are being treated in the force as the persons suffering from illness of permanent nature and, as such, they are either being declared unfit by DPC even though they are otherwise fit for promotion or not even included in the list placed before the DPC for consideration for promotion on the ground that they do not fall in Shape-I category. This is what has exactly happened with the petitioner herein,' the court observed.


Economic Times
17 hours ago
- Economic Times
Promising HIV cure could be achieved through children: Decade long tests reveal
Cure for HIV emerges in children with early antiretroviral treatment New evidence from global HIV research suggests that the first widespread cure for HIV may be possible in children who receive antiretroviral therapy (ART) early in life. Pediatrician and immunologist Philip Goulder from the University of Oxford, working with researchers in South Africa, found that a small subset of HIV-infected infants treated soon after birth can suppress the virus to undetectable levels and maintain remission without ongoing medication for extended periods. After tracking several hundred children infected through mother-to-child transmission, Goulder's team was astonished to find five children who had stopped ART yet showed no viral rebound even after months off medicine, defying the typical two to three weeks it takes for HIV to return when treatment is interrupted. One child maintained remission for an unprecedented 17 months. These children's immune systems appear uniquely capable of controlling HIV independently, a phenomenon not seen in adults despite decades of research. According to Alfredo Tagarro, a pediatrician at the Infanta Sofia University Hospital in Madrid, children living with HIV have often been overlooked in the effort to develop treatments that can achieve permanent remission. Since 2007, about 10 adults are believed to have been cured of HIV through stem cell transplants intended to treat life-threatening blood cancers. While these procedures successfully eradicated the virus, their complexity and significant risks—including several patient deaths—make them an impractical approach for targeting HIV specifically. At the 2025 International AIDS Society conference in Kigali, additional data showed approximately 5% of HIV-positive children initiating ART within six months of birth could reduce the viral reservoir—genetic material of the virus hidden in cells—to negligible levels. Pediatric experts attribute children's more dynamic immune systems and fewer health complications as factors that may enable this early cure. Mark Cotton of the University of Stellenbosch emphasized children's suitability for curative therapies compared to adults with comorbidities. Building on these insights, Goulder has launched a new study involving 19 South African children who have suppressed HIV reservoirs under ART. He plans to carefully discontinue treatment and monitor how many keep the virus suppressed long-term. Early results show six children maintaining remission for more than 18 months without drugs. Boys may have an immunological advantage in controlling HIV due to innate immune system experimental treatments are also being explored in children, including gene therapy designed to make muscle cells continuously produce broadly neutralizing antibodies (bNAbs). This one-time therapy could protect infants in high-prevalence regions by preventing HIV transmission from birth or breastfeeding. Research in newborn monkeys highlights a critical early window post-birth when gene therapy is most effective, potentially revolutionizing pediatric HIV care in resource-limited recent funding setbacks, researchers remain optimistic. Combining ART with bNAbs, vaccines, and gene therapies may jointly corner and eliminate the virus, similar to successful pediatric leukemia treatments. While children represent a minority of global HIV cases, a cure in this group could provide the blueprint for universal HIV eradication global impact could be profound: about 1.7 million children worldwide live with HIV, many in low-income countries where lifelong ART adherence is challenging. An effective cure would drastically reduce the health and social burdens of pediatric HIV and pave the way for transforming HIV from a chronic condition into a curable breakthrough marks a historic turning point in the decades-long fight against HIV, with children potentially leading the route to a cure and offering hope for millions affected worldwide.


Time of India
2 days ago
- Time of India
Gitam institute of medical sciences and research to organise CME on genes, morphology on August 22
Visakhapatnam: The department of anatomy at Gitam institute of medical sciences and research (GIMSR) will organise a programme on continuing medical education (CME) titled 'genes, morphology, and malformations' on August 22. According to head of the department (HoD) Dr Padmini, the CME is designed to enhance knowledge of healthcare professionals in the clinical application of human genetics, with a focus on diagnostic accuracy, ethical decision making and patient centered care. "Participants will gain an in-depth understanding of DNA structure, gene expression, and chromosomal organization essential foundations for interpreting genetic data in clinical practice. The programme will also cover the diagnosis of common genetic and chromosomal disorders such as Down syndrome, cystic fibrosis, and BRCA-related cancers. By integrating genetic principles with real-world clinical scenarios, the event aims to improve diagnostic skills and promote more personalized, patient-focused treatment strategies." "Additionally, the CME will provide hands on training in interpreting genetic test results, with emphasis on understanding their indications, limitations, and clinical relevance. Interested healthcare professionals are requested to register by submitting their details on or before August 1. For more information and registration details, please contact the department of anatomy, GIMSR," Dr Padmini added. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !